NOS3 and metabolic dysfunction-associated steatotic liver disease: The overabundance of lipids and insulin resistance that characterize NAFLD can lead to the downregulation of endothelial nitric oxide synthase (eNOS) activity and upregulation of inducible nitric oxide synthase (iNOS) and NOX1.